Zomedica Corp (NYSEAMERICAN:ZOM) Stock Bounces Back a Bit After The Recent Sell-Off

September 13, 2021

Zomedica Corp (NYSEAMERICAN:ZOM) is an upcoming business in the early growth stages. Such kinds of businesses are riskier stocks to buy relative to established companies. Zomedica will take years before turning a profit, and investors are aware that they are taking a significant risk. However, if the Truforma system, used for animal diagnostics by veterinarians, becomes a hit, early investors will earn massively. It is vital to note that growing…

Read More >>

Zomedica Corp (ZOM) Stock Moves To One Month High On Short Squeeze

August 25, 2021

After struggling since early March, shares of Zomedica Corp (NYSEAMERICAN:ZOM) are witnessing heavy buying interest in the morning session on Thursday. After opening flat, ZOM stock started to pick up solid buying interest in the past few minutes and pushing the stock higher by 27% to trade at the highest point of the session at $0.65. So what’s driving the sudden pop-up? Well, there is no news but one should…

Read More >>

Zomedica Corp (ZOM) Stock Slips Below 50 Cents: But Why?

August 20, 2021

Earlier on this year, Zomedica Corp (NYSEAMERICAN:ZOM) had emerged as a viable option for many investors and the stock had also made considerable gains. However, the situation has changed quite dramatically in recent weeks and retail investors have increasingly headed for the exits. Earlier on in the year the stock had hit its 52 week high of as much as $2.91 a share but on Thursday it closed at only…

Read More >>

Zomedica Corp (ZOM) Stock Plunges Below 50 Cents: Time To Panic?

August 12, 2021

On Wednesday, Zomedica Corp (NYSEAMERICAN:ZOM) announced its financial results for the second fiscal quarter but it seems that the market is not impressed by its performance and the stock has already declined by as much as 13% during the premarket trading period to $0.49. The veterinary health firm, which is known for its point of care diagnostics solutions for pets, suffered a loss of $4.6 million during the quarter, which…

Read More >>

Will Zomedica (ZOM) Stock Recover After The Recent Fall?

August 2, 2021

Zomedica (NYSEAMERICAN:ZOM) is currently at $0.64 per share. It may seem like a considerable risk for investors especially considering that for a long period in 2020, the stock was trading under a dime. According to the company’s announcement of 2020 financial results, it is still in the development stage, and it has no revenue. The company reported a net loss of around $16.9 million or $0.05 per share. Ordinarily, most…

Read More >>